<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>label expansion on FinanClub</title>
    <link>https://finan.club/tags/label-expansion/</link>
    <description>Recent content in label expansion on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 27 Aug 2023 10:33:03 +0000</lastBuildDate><atom:link href="https://finan.club/tags/label-expansion/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BMY</title>
      <link>https://finan.club/us/bmy/</link>
      <pubDate>Sun, 27 Aug 2023 10:33:03 +0000</pubDate>
      
      <guid>https://finan.club/us/bmy/</guid>
      <description>score:0
Chances: Bristol Myers&amp;rsquo; Opdivo receives European Commission approval for label expansion. Bristol Myers Squibb showcases positive updated NSCLC data. Bristol Myers Squibb launches Clear Understanding Campaign for plaque psoriasis. Bristol Myers Squibb progresses in environmental, social, and governance initiatives. Bristol Myers Squibb enters $4 billion accelerated share repurchase agreements.</description>
    </item>
    
  </channel>
</rss>
